Prenostics Information

Prenostics is on a mission to make cancer predictable and preventable. As a professor of cancer research at the University of Oxford and a practicing oncologist, Prenostic's founder Sarah Blagden has worked for more than two decades to challenge the perception that cancer is unavoidable. Her research revealed a new biomarker of precancer, a way of detecting the disease years in advance of it manifesting in the body. This led to the launch of the Prenostics test, a blood test that identifies precancers. You can learn more about Prenostics at our website.